Ann-Lise works toward improving access and affordability to health products, focusing on low-and middle-income countries and engaging in multi-stakeholder initiatives to encourage innovation and strengthen health systems.
She supports policy development on these topics as well as the strategic engagement with key international stakeholders, including WHO.
Before she joined IFPMA, Ann-Lise was part of the Public Affairs team for Sanofi Global Health, where she promoted the value of the Sanofi Global Health’s portfolio in NCDs,TB, malaria, and AMR.
Prior to this, Ann-Lise gained a wide range of experience in market access, medical affairs, and medico-economics at MSD France, the French Health Technology Assessment Agency (Haute Autorité de Santé), and the University Hospitals of Bordeaux and Toulouse in France.
Ann-Lise has a PharmD with a specialization in Hospital Pharmacy, with complementary diplomas in medico-economics, global health, and statistics for medical trials.
Working at IFPMA allows me to interact with incredibly skilled and expert colleagues, members, and external stakeholders. Its status offers the opportunity to collaborate with a wide range of key global health actors, whose shared objectives foster constructive cross-sectoral agendas.
More from Ann-Lise
Renewing industry’s commitment to better access to diabetes care on World Diabetes Day
This World Diabetes Day (WDD), IFPMA and its members are renewing our commitment to take proactive steps to improve access to diabetes care and make progress toward the achievement of SDG target 3.4.Read more
Innovative partnership model to improve access to cancer care in LMICs
Through public and private sector partnerships, a global initiative innovates for better access to cancer care worldwide.Read more
Caring for chronic diseases in lower-resource settings
In the wake of COVID-19, lower-resourced settings need sustainable healthcare more than ever to build back better. Promising solutions are at hand.Read more